John Militello - 17 May 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role: VP, Principal Accounting Officer and Interim Principal Financial Officer
Signature: /s/ Martin Wilson, as attorney-in-fact for John Militello
Issuer symbol: RCKT
Transactions as of: 17 May 2023
Net transactions value: -$5,237
Form type: 4
Filing time: 19 May 2023, 16:05:30 UTC
Previous filing: 16 May 2023
Next filing: 20 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCKT	Common Stock	Sale	$5,237	-245	-3.9%	$21.38	6,116	17 May 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

Remarks:

VP, Principal Accounting Officer and Interim Principal Financial Officer